Eye fundus colour images enhancement service for Diabetic Retinopathy diagnosis
Diabetic retinopathy (DR) is considered as a priority eye disease by the World Health Organisation, as one of the main causes of visual impairment. It is a complication of the eye that can affect anyone who has diabetes. Diabetic...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
Spectra
Spectra A novel diagnostic device to improve retinal imagin...
71K€
Cerrado
iScan
Automated retinal scans for early detection of diabetic eye...
4M€
Cerrado
iScan
Automated retinal scans for early detection of diabetic eye...
71K€
Cerrado
Smartscope-X
Affordable accessible and automatic screening solution for...
3M€
Cerrado
TIN2013-46751-R
ANALISIS DE IMAGEN DE FONDO DE OJO PARA CRIBADO AUTOMATICO D...
169K€
Cerrado
aiVision
Innovative AI based Ophthalmologic Diagnosis
71K€
Cerrado
Información proyecto Eye Light
Duración del proyecto: 6 meses
Fecha Inicio: 2016-02-25
Fecha Fin: 2016-08-31
Líder del proyecto
IPRI SERVICES
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Diabetic retinopathy (DR) is considered as a priority eye disease by the World Health Organisation, as one of the main causes of visual impairment. It is a complication of the eye that can affect anyone who has diabetes. Diabetic retinopathy causes damage to the blood vessels supplying the retina – the seeing part of the eye. Because retinopathy generally has no obvious symptoms until it is advanced, early detection is essential. Detection is made by retinal screening. This is a straightforward procedure which includes assessment of visual acuity and eye fundus photography. Then a medical specialist, who looks for signs of diabetic retinopathy, gives a grade allowing a further diagnosis. This makes the diagnosis heavily dependent on the image quality. iPRI, which current activity is based on consulting expertise in public health, has identified a need for delivering a practical solution to the DR diagnosis challenge. iPRI has created a new prototype of software to enhance the quality of colour eye fundus exams. Several tests on representative databases have shown to DR experts that there is an important medical interest to introduce this service in the diagnostic procedure. IPRI’s international network of Key Opinion Leaders in Diabetes has confirmed this interest. Through the EYE-LIGHT project, iPRI aims to integrate this proven technology into a medical device. It will be provided as a professional application software service in order to facilitate the DR diagnosis, improve the image quality, allow comparisons and make images sharable through telemedicine. In order to address the unmet medical need, iPRI has to scale up, industrialise and sell this medical device. Through the SME Instrument programme, iPRI intends to refine the business model of this new activity during phase 1, and to set up and clinically validate the medical device during phase 2.